Investment Opportunity In New Diagnostic Center In Hyderabad
About Business
The company is seeking strategic investors/partners to support the expansion plan. The proposed investment will primarily be allocated towards:
- Acquisition of MRI, Ultrasound, and Digital X-Ray machines
- Establishment of pathology labs with modern automation systems
- Infrastructure development and licensing (Clinical Establishment, AERB, PCPNDT, NABL accreditation)
- Technology integration, including software for online booking and report management
- Marketing and brand building
Existing Business Operations
The business is actively engaged in medical equipment trading, including products such as Phillips oxygen systems, anesthesia machines, and ventilators. In the last financial year, it successfully closed six deals. The company also undertakes complete hospital set-ups across India and has earned a strong reputation for reliable after-sales service.
Expansion Plan
The company is now planning to expand into diagnostics with the acquisition of ultrasound and MRI machines. A leased space has already been secured for the upcoming center. The business benefits from established relationships and goodwill with surgeons and doctors, ensuring a strong referral network.
Additionally, the company has recently diversified into international medical tourism, further broadening its service portfolio and growth potential.
Clientele type
Doctors
Premises
LEASED
Lease per month (in INR): 15.00 K
Security Deposit (in INR): 2.00 L
Carpet Area: 700 sq ft
Asking Price Includes
The terms of the transaction will be discussed with the potentail investor.
Asking Price
INR 2.00 Cr
Minimum ticket size
INR 2.00 Cr
Reason
To establish a new diagnosis center, the founder is looking for an investor.
Licenses
Drug License Incorporation certificate GST all documents available
More Details
The founder is a biotech engineer with strong domain knowledge and a deep understanding of the healthcare sector.
Keywords
Business Tags
Fundraising for ₹10 Cr – 500 Cr
Confidential Process Completed in 120 Days
Strategic Preparation, Aligned Investor Outreach and Seamless Closure
Supported by Advisors with 26+ Years of Experience